Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Csl Behring

Clinical trials sponsored by Csl Behring, explained in plain language.

Now part of CSL Limited CSL ASX

Makes plasma-derived and recombinant therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 14 Not yet recruiting 2 Not yet finished but already full! 1 Completed 11 Terminated 3

New hope for hemophilia a: experimental clotting factor shows promise in chinese trial

Disease control Ongoing

This phase 3 trial is testing a new form of factor VIII (rVIII-SingleChain) in 60 Chinese men with severe hemophilia A. The goal is to see how well the drug works to prevent and treat bleeding episodes when given 2-3 times per week. Researchers will also check how the body proces…

Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC